SCHEMBL23285181

SCHEMBL23285181

CCCc1ccccc1[C@@H](C)c1ccc(F)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.39
ADRA2A P08913 2/20 0.39
ADRA2B P18089 2/20 0.39
ADRA2C P18825 2/20 0.39
ALDH1A1 P00352 2/20 0.38
KMT2A Q03164 1/20 0.36
SLC6A2 P23975 1/20 0.36
KDM4E B2RXH2 1/20 0.34
MAPK1 P28482 1/20 0.34
GCGR P47871 1/20 0.34
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
HTR7 P34969 1/20 0.33
HTR6 P50406 1/20 0.33
HTR1A P08908 1/20 0.33
DAO P14920 1/20 0.33
MC4R P32245 1/20 0.33
HRH4 Q9H3N8 1/20 0.33
ALOX5AP P20292 1/20 0.33
F2RL1 P55085 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25482210 0.86 ALDH1A1 (0.43) SLC6A4ALDH1A1KMT2ASLC6A2KDM4E
SCHEMBL6546081 0.86 ADRA2A (0.42) SLC6A4ADRA2AADRA2BADRA2CKMT2A
SCHEMBL10602405 0.83 ADRA2A (0.40) SLC6A4ADRA2AADRA2BADRA2CKMT2A
SCHEMBL9621039 0.82 ADRA2A (0.46) SLC6A4ADRA2AADRA2BADRA2CSLC6A2
SCHEMBL21095743 0.80 F2RL1 (0.39) SLC6A4ADRA2AADRA2BADRA2CSLC6A2
SCHEMBL6547601 0.76 CYSLTR2 (0.46) SLC6A4HTR2A
SCHEMBL10389148 0.74 ALDH1A1 (0.41) SLC6A4ALDH1A1KMT2ASLC6A2KDM4E
SCHEMBL4843352 0.74 ADRA2A (0.46) ADRA2AADRA2BADRA2CSLC6A2HTR2C
SCHEMBL8679324 0.74 SLC6A4 (0.42) SLC6A4KMT2ASLC6A2
SCHEMBL6546993 0.74 ADRA2A (0.44) ADRA2AADRA2BADRA2CHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021081272-A1 PROGRANULIN MODULATORS AND METHODS OF USING THE SAME ARKUDA THERAPEUTICS (US) 2021-04-29 WO disclosed